Blood Cancer Advances May Improve Survival
Drugs seem to benefit patients with multiple myeloma, acute lymphoblastic leukemia, researchers sayContinue Reading
Drugs seem to benefit patients with multiple myeloma, acute lymphoblastic leukemia, researchers sayContinue Reading
Common warning signs of abnormal bleedingContinue Reading
Deaths, complications have plummeted among patients, researchers findContinue Reading
Some patients still face clot risk after the artery-opening procedure, researchers explainContinue Reading
Adequate levels were linked to longer survival, researchers reportContinue Reading
Small Swedish study refutes conventional wisdom, but some experts skepticalContinue Reading
Study found patients with acute myeloid leukemia who had the variant were more likely to die quicklyContinue Reading
Inconsistent surveillance practices threaten validity of rankings, researchers sayContinue Reading
Discovery could benefit surgical, cancer, anemia patients, researchers sayContinue Reading
Those without blood disorder who were given it were twice as likely to have trouble, review foundContinue Reading
New guidelines issued for drugs that reduce transfusion riskContinue Reading
Home tests show promise for patients taking warfarin, study findsContinue Reading
Small minority of CML patients went off the drug for 2 years with no sign of recurrenceContinue Reading
More research needed on optimum dose, despite stroke risk posed by drugs, panel members sayContinue Reading
© 2021 TheHealthCast.com - All Rights Reserved.